PCR 2015 presents the findings of a new global study of PCR that profiled the laboratory use of this technique across research, life science and clinical sectors. This study, which evaluated end-users' current practices and three-year plans, investigated their own estimates of the growth in their use of this technique, the competitive positions of global instrument suppliers; PCR instruments used; research and clinical applications, consumables suppliers; PCR software; end-user's views on their future innovation and development needs in this field; sample preparation steps and methods; sample types analysed; main activities; disease areas; disease biomarkers; costs of sample analysis; sample throughput per month and other areas. This study involved the participation of 425 PCR end-users, whose average level of experience in the use of this technique, was approximately 14 years. Findings on the global regions of participants show that Europe (the largest region at 52%) and North America (15%), account for around 67% of participants.



In addition to the analysis provided in this report, purchasers of the global license also receive the full raw data from this study, in excel format. This allows additional sector and segment analysis across all market areas covered in this study.


PCR is one of the most widely used laboratory techniques today, and is indispensable to many applications in research and the clinic. This technique has also seen important advances over the last decade, as end-users seek methods that are faster, offer higher throughputs, reduced costs, improved sensitivities and other advances. The use of PCR continues to grow as requirements increase and new applications are developed.


Research Use of PCR

  • Growth in PCR tests, and anticipated in 3 years (±% change)
  • Suppliers of instruments and anticipated in 3 years (±% change)
  • PCR Instruments and anticipated in 3 years (±% change)
  • Suppliers of PCR consumables, and anticipated in 3 years (±% change)
  • Cost factors of PCR consumables, and anticipated in 3 years (±% change)
  • PCR techniques used now, and anticipated in 3 years (±% change)
  • Research applications of PCR and anticipated in 3 years (±% change)
  • Software used by end-users in their PCR activities
  • End-user's future PCR innovation and development needs
  • Sample preparation steps and methods used by PCR end-users
  • Diseases studied now using PCR, and anticipated in 3 years
  • Sample types analysed, and anticipated in 3 years (±% change)
  • Main activities of PCR end-users


Clinical Use of PCR

  • Growth in PCR tests, and anticipated in 3 years (±% change)
  • Suppliers of instruments and anticipated in 3 years (±% change)
  • PCR Instruments and anticipated in 3 years (±% change)
  • Suppliers of PCR consumables, and anticipated in 3 years (±% change)
  • Cost factors of PCR consumables, and anticipated in 3 years (±% change)
  • PCR techniques used now, and anticipated in 3 years (±% change)
  • Clinical applications of PCR and anticipated in 3 years (±% change)
  • Software used by end-users in their PCR activities
  • End-user's future PCR innovation and development needs
  • Sample preparation steps and methods used by PCR end-users
  • Diseases studied now using PCR, and anticipated in 3 years
  • Sample types analysed, and anticipated in 3 years (±% change)
  • Main activities of PCR end-users


Other Areas

  • Disease biomarker molecules studied by end-users, using PCR
  • Disease areas relating to end-users studies of disease biomarkers, using PCR
  • Purpose of end-users studies of disease biomarkers, using PCR
  • Clinical utilities of end-users biomarkers studies, using PCR
  • Costs of sample analysis estimated by end users, using PCR
  • Average monthly throughput of samples by end users, using PCR
  • End-user's experience using PCR
  • Participant's job title, role and main activities
  • Countries and global regions
  • Organisation type